Evidence map›Paper›PMID 9303309›Full record

ArticleThe EMBO journal1997

Inhibition of apoptosis by the actin-regulatory protein gelsolin.

M Ohtsu, N Sakai, H Fujita, M Kashiwagi, S Gasa, S Shimizu, Y Eguchi, Y Tsujimoto, Y Sakiyama, K Kobayashi and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 140 citations in OpenAlex.

  1. Review
  2. Article
  3. Gelsolin as a predictor of arteriovenous fistula maturation.Clinical and experimental nephrology · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Regulation of Mitochondrial Function by the Actin Cytoskeleton.Frontiers in cell and developmental biology · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Cytoskeletal Regulation of Oligodendrocyte Differentiation and Myelination.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The protective effects of plasma gelsolin on stroke outcome in rats.Experimental & translational stroke medicine · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

M OhtsuCancer Institute and Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan.
N Sakai
H Fujita
M Kashiwagi
S Gasa
S Shimizu
Y Eguchi
Y Tsujimoto
Y Sakiyama
K Kobayashi
N Kuzumaki
Hokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gelsolin is an actin-regulatory protein that modulates actin assembly and disassembly, and is believed to regulate cell motility in vivo through modulation of the actin network. In addition to its actin-regulatory function, gelsolin has also been proposed to affect cell growth. Our present experiments have tested the possible involvement of gelsolin in the regulation of apoptosis, which is significantly affected by growth. When overexpressed in Jurkat cells, gelsolin strongly inhibited apoptosis induced by anti-Fas antibody, C2-ceramide or dexamethasone, without changing the F-actin morphology or the levels of Fas or Bcl-2 family proteins. Upon the induction of apoptosis, an increase in CPP32(-like) protease activity was observed in the control vector transfectants, while it was strongly suppressed in the gelsolin transfectants. Pro-CPP32 protein, an inactive form of CPP32 protease, remained uncleaved by anti-Fas treatment in the gelsolin transfectants, indicating that gelsolin blocks upstream of this protease. The tetrapeptide inhibitor of CPP32(-like) proteases strongly inhibited Fas-mediated apoptosis, but only partially suppressed both C2-ceramide- and dexamethasone-induced apoptosis. These data suggest that the critical target responsible for the execution of apoptosis may exist upstream of CPP32(-like) proteases in Jurkat cells and that gelsolin acts on this target to inhibit the apoptotic cell death program.

Indexed as

CaspasesActinsApoptosisCaspase 1Caspase 3Cysteine EndopeptidasesCysteine Proteinase InhibitorsEnzyme Activationfas ReceptorGelsolinHumansJurkat CellsProto-Oncogene Proteins c-bcl-2TransfectionActinsCASP3 protein, humanCaspase 1Caspase 3CaspasesCysteine EndopeptidasesCysteine Proteinase Inhibitorsfas ReceptorGelsolinProto-Oncogene Proteins c-bcl-2

Identifiers

PMID9303309
PMCPMC1170091
OpenAlexW2159758114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.